基本信息
浏览量:76
职业迁徙
个人简介
My long term career objective has been to provide molecular targets, develop tools and characterize models to encourage greater pharmaceutical investment in disease-modifying therapeutics aimed at neuroprotection (‘precision medicine’). I have long had an interest in dementia, from my PhD dissertation was on ‘The genetics of age-associated cognitive dysfunction in Down syndrome’, including the role of APOE, to linkage analysis implicating increased alpha-synuclein gene dosage as the cause of Lewy body parkinsonism-dementia, to comparative high-throughput sequencing in families and populations to identify the genetic contribution to neurodegenerative trait components. I have used genetic insights to better understand genotype-phenotype correlations in man and in mouse models, with cre-loxP methods and brain slice biochemistry and physiology. In recent years I built and directed the Centre for Applied Neurogenetics and Translational Neuroscience at the University of British Columbia, and founded Neurocode Labs Inc., the only company in Canada that is clinically-accredited in medical genetics to return results from whole exome sequencing, primarily in the context of pediatric seizure disorders. As part of both endeavors, integrating genetic information, bioinformatics and web-development, my team created NeuroSeq (www.neuroseq.ca), a genome browser to enable sharing and global collaboration between neurologists and academic researchers. This proposal is a community-based effort focused on brain health and neuroprotection that aims to understand what it will take to deliver genetic information to the public. We aim to lower the risk of cognitive decline and dementia, in an underserved and socioeconomically disadvantaged sample from the population of Florida, in a meaningful and ethically-responsible fashion. It is a pilot application to improve population health, methodologically simplistic but nonetheless challenging in that it aims to modify individual behavior to lower the overall risk and incidence of Alzheimer’s disease.
研究兴趣
论文共 611 篇作者统计合作学者相似作者
按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选
时间
引用量
主题
期刊级别
合作者
合作机构
medRxiv : the preprint server for health sciences (2024)
MOVEMENT DISORDERSno. 2 (2024): 249-258
Jordan Follett, Dylan Guenther, Leyna Xoi,Rim Amouri,Samia Ben Sassi,Faycel Hentati,Matthew J Farrer
Movement disorders : official journal of the Movement Disorder Societyno. 4 (2024): 751-753
Movement disorders : official journal of the Movement Disorder Societyno. 10 (2023): 1837-1849
medRxiv (Cold Spring Harbor Laboratory)no. 1 (2023): 1-8
medRxiv : the preprint server for health sciences (2023)
npj Parkinson's Diseaseno. 1 (2023): 1-11
Zenodo (CERN European Organization for Nuclear Research) (2023)
Amica C Müller-Nedebock,Marieke C J Dekker,Matthew J Farrer,Nobutaka Hattori, Shen-Yang Lim,George D Mellick,Irena Rektorová,Mohamed Salama, Artur F S Schuh,A Jon Stoessl,Carolyn M Sue,Ai Huey Tan,
NPJ Parkinson's diseaseno. 1 (2023): 110-110
加载更多
作者统计
合作学者
合作机构
D-Core
- 合作者
- 学生
- 导师
数据免责声明
页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果,我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问,可以通过电子邮件方式联系我们:report@aminer.cn